Buy & Sell Abbott Laboratories (ABT) – Abbott Laboratories Price Today
Aura AI Summary
Key Stats
- $147.13BMarket Cap
- HealthSector
- -29.01%3M Drawdown
- $173.88BEnterprise Value
- 2.98%Dividend Yield
- 95 daysTypical Hold Time
Abbott Laboratories (ABT) is currently valued at a market capitalization of $147.13B, with an enterprise value of $173.88B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $138.08, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -29.01%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 2.98%, with the most recent dividend of $0.63 paid on 15 Apr 26. On average, investors hold Abbott Laboratories for approximately 95 days, indicating typical investor behavior on the platform.
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Most Recent News
Sitryx Therapeutics to present at major healthcare investor conferences in June 2026
Sitryx Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced its management will participate in three key investor conferences in June 2026: Jefferies Global Healthcare Conference in New Y...
Regeneron shares drop 10% after Phase 3 melanoma trial misses primary endpoint.
Regeneron Pharmaceuticals' stock fell over 10% following the Phase 3 trial results for their melanoma treatment combining fianlimab and cemiplimab. The trial did not achieve statistical significance for the primary endpoint of progression-free surviv...
Auddia highlights $29B AI infrastructure potential via LT350's GPU-powered parking lot data centers.
Auddia Inc. spotlighted the AI infrastructure opportunity of its LT350 subsidiary, referencing a $1.25 billion GPU cloud contract by SharonAI as a market benchmark. LT350's patented design uses parking lot airspace to deploy up to 960,000 GPUs, poten...
